BCT
$6.00
-2.755%
BriaCell Therapeutics Corp.News & Events
Last updated: Apr 17, 2025, 9:22 PM ET
BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer
GlobeNewswire APR 16, 2025 7:30 AM EDTMedian overall survival of 17.3 months in Bria-IMT™ treated patients with hormone receptor...READ ARTICLEBriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3
GlobeNewswire APR 10, 2025 8:00 AM EDTBriaPro is developing novel antibodies to B7-H3, a key cancer antigen and immune checkpoint ...READ ARTICLEBriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference
GlobeNewswire MAR 26, 2025 8:00 AM EDTPHILADELPHIA and VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- BriaCell Therape...READ ARTICLESecond Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell's Phase 3 Study in Metastatic Breast Cancer
GlobeNewswire MAR 20, 2025 8:00 AM EDTThe Data Safety Monitoring Board (DSMB) identified no safety concerns, and recommended continuati...READ ARTICLEBriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
GlobeNewswire FEB 5, 2025 6:15 PM ESTPHILADELPHIA, Pa. and VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) -- BriaCell T...READ ARTICLEBriaCell Therapeutics Announces Closing of Public Offering
GlobeNewswire FEB 5, 2025 4:05 PM ESTPHILADELPHIA and VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeu...READ ARTICLEBriaCell Therapeutics Announces Pricing of Public Offering
GlobeNewswire FEB 3, 2025 7:59 PM ESTPHILADELPHIA and VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeu...READ ARTICLEBriaCell Therapeutics Announces Proposed Public Offering of Common Shares
GlobeNewswire FEB 3, 2025 4:45 PM ESTPHILADELPHIA and VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeu...READ ARTICLEBriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS(TM)
GlobeNewswire FEB 3, 2025 7:30 AM ESTLung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treat...READ ARTICLEBriaCell Announces Completion of 15:1 Share Consolidation
GlobeNewswire JAN 27, 2025 6:42 PM ESTPHILADELPHIA and VANCOUVER, British Columbia, Jan. 27, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeu...READ ARTICLE